Company Overview
JASPER THERAPEUTICS, INC.
JSPRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-76M
2025 FY
Shares Outstanding
19M
2025 FY
EPS
-3.95USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1788028
Exchange
Nasdaq
Location
US